# Evolv Technologies Holdings, Inc.: Form 10-Q/A for the period ended Mar 31, 2022

- Company: [Evolv Technologies Holdings, Inc.](/companies/evlv.md) (CIK 1805385)
- Form: 10-Q/A
- Filed: 2022-05-16
- Accepted by EDGAR: May 13, 2022, 19:25 ET
- Period: 2022-03-31
- Accession: 0001558370-22-008811
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1805385/000155837022008811/nhic-20220331x10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1805385/000155837022008811/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2022-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2022-01-01 to 2022-03-31 | $8.7m | us-gaap:Revenues |
| Cost of revenue | 3 months, 2022-01-01 to 2022-03-31 | $7.1m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2022-01-01 to 2022-03-31 | $1.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2022-01-01 to 2022-03-31 | $4.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2022-01-01 to 2022-03-31 | −$25.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2022-01-01 to 2022-03-31 | $142.0k | us-gaap:InterestExpense |
| Income tax | 3 months, 2022-01-01 to 2022-03-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2022-01-01 to 2022-03-31 | −$14.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2022-01-01 to 2022-03-31 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2022-01-01 to 2022-03-31 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2022-01-01 to 2022-03-31 | 142,878,406 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2022-01-01 to 2022-03-31 | −$35.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2022-01-01 to 2022-03-31 | $323.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2022-03-31 | $270.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2022-03-31 | $307.2m | us-gaap:AssetsCurrent |
| Total assets | at 2022-03-31 | $343.9m | us-gaap:Assets |
| Current liabilities | at 2022-03-31 | $23.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2022-03-31 | $63.8m | us-gaap:Liabilities |
| Long-term debt | at 2022-03-31 | $7.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | at 2022-03-31 | $3.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | at 2022-03-31 | $280.1m | us-gaap:StockholdersEquity |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1805385/000155837022008811/nhic-20220331x10qa.htm

Filed May 16, 2022.
Source: SEC EDGAR, the filing index for accession 0001558370-22-008811. Last ingested by Listed: Nov 11, 2026, 03:09 ET. No prices; not investment advice.
